Multiple Sclerosis therapy from Stem Cells

Overcoming Multiple Sclerosis: An Evidence-Based Guide to Recovery

Everyday new avenues are being explored to find novel therapies for hard to treat diseases. One exciting new approach is the use of autologous Adult Stem Cells. Multiple Sclerosis (MS) is one of the many notable diseases adult stem cell therapy could potentially impact. Multiple Sclerosis (MS) is a disorder in which an individual’s own immune system attacks the ‘myelin sheath’. The myelin sheath serves to protect the nerve cells within the body’s central nervous system (CNS). In addition to fatigue and depression, the damage caused by MS may result in many types of mild and severe symptoms including:

Numbness in the limbs
Muscle control problems
Paralysis
Loss of vision
Loss of balance
Speech and Swallowing Problems
Cognitive difficulties
Tremors
Dizziness
Heat Sensitivity

The progression, severity, and specific symptoms of MS are unpredictable and vary from one person to another. Currently there is no cure for MS, but ms stem cell therapies attempt to slow the disease’s progression and limit symptoms. Although not a cure for MS, the use of adult stem cells for MS therapy may be of significant value. This is due to the ability of adult stem cells to differentiate into many different types of cells, such as those required for proper functioning and protection of nerve cells. As such, treatment in the early stages of MS could potentially be of the most benefit. Advantageously, adult stem cells can be isolated with relative ease from an individual’s own ‘adipose’ (fat) tissue, and so adult stem cell therapy is not subject to the ethical or religious issues troubling some other methods.

StemGenex™, a US based company, is pioneering new methods for using adipose derived adult stem cells to help in diseases with limited treatment options. As such, StemGenex has been conducting research with scientists and physicians over the last 6 years to specifically advance adult stem cell treatment protocols for alleviating MS symptoms. StemGenex findings include the use of a double activation proprietary process, to increase the viability and quantity of stem cells received in one application.

“A larger volume of activated stem cells in an application has improved MS patient’s response to treatment.”
“Perhaps more focus on research and MS is a top responding condition to adipose-derived stem cell treatment.”
“Stem cells have proven to slow or halt the progression of the disease and substantially improve the quality of life”
“List the various advantages to having stem cell treatment early in an MS diagnosis.”

Rita Alexander, the President of StemGenex™, says, “We are building on our recent research and positive results into potential ms stem cell treatments. Although these future treatments are not going to be a cure for MS, we are hoping to see at the end point potential benefits for treating MS individuals with adult stem cells”.

from http://www.stemgenex.com/blog/adultstemcellbasedtherapyformultiplesclerosis.html

Incoming search terms:

Multiple Sclerosis Stem Cell Latest News, stemgenex, stemgenex and fda, rita alexander stem cell, latest on multiple sclerosisstem cell research atp, stemgenix fda.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>